stars 1 stars 2 stars 3

The European Diabetes Study Center has gathered a team of renowned scientific and medical experts, pioneers in their field of expertise, to fund a biotech company, ILONOV, focused on developing a novel class of therapeutics using the therapeutic potential of our muscle-derived biologic. We aim at satisfying unmet medical needs in Type 1 Diabetes therapy by bringing to the market a first-in-class treatment for curing and preventing T1D and using our discovery to open up a new field of therapeutics.

Employees 7 (4 on RocketReach)
Founded 2020
Address Boulevard René Leriche, Strasbourg, Grand Est 67200, FR
Industry Biotechnology Research

ILONOV Questions

Anastasia Grabarz is the CEO of ILONOV.

4 people are employed at ILONOV.

ILONOV is based in Strasbourg, Grand Est.

Top ILONOV Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users